Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29516177 | 1.00 | HTR2A (0.60) | HTR2AL3MBTL1ALDH1A1HSD17B10HIF1A | |
| SCHEMBL83486 | 0.83 | ALDH1A1 (0.56) | HTR2AL3MBTL1ALDH1A1HSD17B10HIF1A | |
| SCHEMBL9646318 | 0.82 | HTR2A (0.47) | HTR2AL3MBTL1ALDH1A1HSD17B10HIF1A | |
| SCHEMBL337526 | 0.82 | ALDH1A1 (0.54) | HTR2AL3MBTL1ALDH1A1HSD17B10HIF1A | |
| SCHEMBL5270482 | 0.81 | HTR2A (0.56) | HTR2AL3MBTL1ALDH1A1HSD17B10HIF1A | |
| SCHEMBL1719724 | 0.81 | ALDH1A1 (0.45) | HTR2AL3MBTL1ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL29791960 | 0.81 | ALDH1A1 (0.45) | HTR2AL3MBTL1ALDH1A1HSD17B10CYP1A2 | |
| SCHEMBL16671492 | 0.80 | L3MBTL1 (0.46) | HTR2AL3MBTL1ALDH1A1HSD17B10HIF1A | |
| SCHEMBL23527427 | 0.79 | HTR2A (0.65) | HTR2AL3MBTL1ALDH1A1HSD17B10HIF1A | |
| SCHEMBL9445712 | 0.79 | HTR2A (0.65) | HTR2AL3MBTL1ALDH1A1HSD17B10HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025774-A | Epoxy adhesive with high temperature resistance and preparation process thereof | 东莞以科美胶粘科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-115850002-B | Method for hydrodehalogenating halogenated alkane | 中国科学院兰州化学物理研究所 | 2025-05-23 | — | — | CN | claimed |
| CN-115417979-B | Azobenzene liquid crystal polymer and preparation method and application thereof | 广东省科学院生物与医学工程研究所 | 2024-01-30 | — | — | CN | claimed |
| CN-115521653-A | Conjugated ionic liquid stripping modified graphene conductive agent, conductive electrode slice and preparation method thereof | 深圳前海石墨烯产业有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-115417979-A | Azobenzene liquid crystal polymer and preparation method and application thereof | 广东省科学院生物与医学工程研究所 | 2022-12-02 | — | — | CN | claimed |
| CN-108912311-A | A kind of polyfluorene and the preparation method and application thereof of the side group containing anthryl group | 华南理工大学 | 2018-11-30 | — | — | CN | claimed |
| CN-108264628-A | A kind of preparation method of the shape-memory polymer with ultraviolet light intelligence shape switch | 哈尔滨工业大学 | 2018-07-10 | — | — | CN | claimed |
| EP-3808750-B1 | TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING ENE COMPOUND, AND METHOD FOR ANALYZING ENE COMPOUND | TOKUYAMA CORP (JP) | 2026-04-01 | — | — | EP | disclosed |
| EP-4691558-A2 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | University Court of The University of Dundee (GB) | 2026-02-11 | — | — | EP | disclosed |
| EP-4678690-A1 | ALKALINE HYDROLYSIS OF POLYETHYLENE TEREPHTHALATE USING PHASE TRANSFER CATALYSIS | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin (IE) | 2026-01-14 | — | — | EP | disclosed |
| US-20250295789-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2025-09-25 | — | — | US | disclosed |
| EP-2857018-B1 | Treatment or prophylaxis of proliferative conditions | UNIV COURT OF THE UNIV OF DUNDEE (GB) | 2025-09-03 | — | — | EP | disclosed |
| CN-120208862-A | Triphenylamine derivative, preparation method thereof and application thereof in killing gram-positive bacteria | 上海大学 | 2025-06-27 | — | — | CN | disclosed |
| EP-0021234-B1 | NONAPEPTIDE AND DECAPEPTIDE DERIVATIVES OF LUTEINIZING HORMONE RELEASING HORMONE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SYNTEX (U.S.A.) INC. (US) | 1984-08-22 | — | — | EP | disclosed |
| US-4419347-A | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists | SYNTEX (U.S.A.) INC. (US) | 1983-12-06 | — | — | US | disclosed |
| US-4341767-A | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists | SYNTEX INC. (US) | 1982-07-27 | — | — | US | disclosed |
| EP-0049628-A2 | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists, methods of making them, and their pharmaceutical uses | SYNTEX (U.S.A.) INC. (US) | 1982-04-14 | — | — | EP | disclosed |
| US-4324681-A | Chiral supports for resolution of racemates | UOP INC. (US) | 1982-04-13 | — | — | US | disclosed |
| EP-0021234-A1 | Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone, their preparation and pharmaceutical compositions containing them | SYNTEX (U.S.A.) INC. (US) | 1981-01-07 | — | — | EP | disclosed |
| US-4234571-A | CONTRACEPTIVES, ANTIFERTILITY AGENTS | SYNTEX (U.S.A.) INC. (US) | 1980-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295789-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | CYP1B1, BRCA1, UGT1A1 | HTR2A 2049/4885L3MBTL1 3151/4885ALDH1A1 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.